- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (311)
- Timeline of Article Publication (1)
- Authors Evaluation (1)
- Article Quality Tracking (2)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6052)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 21, 2023 (publication date) through Mar 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Peverelle M, Ng J, Peverelle J, Hirsch RD, Testro A. Liver decompensation after rapid weight loss from semaglutide in a patient with non-alcoholic steatohepatitis -associated cirrhosis. World J Gastroenterol 2023; 29(47): 6165-6167 [PMID: 38186682 DOI: 10.3748/wjg.v29.i47.6165] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i47/6165.htm |
| Number | Citing Articles |
| 1 |
Jordan S. Woodard, Jena Velji-Ibrahim, Jay Alden, Gary A. Abrams, Yoshifumi Nakayama. VCTE Overestimates Liver Fibrosis due to Abdominal–Truncal Adiposity and Not Hepatic Steatosis: A Case Report. Case Reports in Gastrointestinal Medicine 2024; 2024(1) doi: 10.1155/2024/7938701
|
| 2 |
Brian J. Wentworth. Metabolic dysfunction-associated steatotic liver disease throughout the liver transplant cycle: a comprehensive review. Metabolism and Target Organ Damage 2024; 4(4) doi: 10.20517/mtod.2024.45
|
| 3 |
|
| 4 |
Eda Kaya, Wing-Kin Syn, Paul Manka. Glucagon like peptide-1 receptor agonists as a promising therapeutic option of metabolic dysfunction associated steatotic liver disease and obesity: hitting two targets with one shot. Current Opinion in Gastroenterology 2025; doi: 10.1097/MOG.0000000000001083
|